What is the treatment approach for a patient with lactate acidosis, potentially induced by medications such as metformin?

Treatment of Lactic Acidosis

Immediate Management: Discontinue Metformin and Treat the Underlying Cause

The cornerstone of treating lactic acidosis—particularly when metformin-associated—is immediate discontinuation of metformin, aggressive treatment of the underlying condition (sepsis, shock, hypoxia), and prompt hemodialysis for severe cases with metformin levels >5 mcg/mL or lactate >5 mmol/L. 1, 2, 3

Step 1: Discontinue Metformin Immediately

• Stop metformin at presentation in any patient with suspected lactic acidosis, especially if lactate >5 mmol/L, pH ≤7.35, or anion gap acidosis is present 1
• Metformin-associated lactic acidosis (MALA) is characterized by elevated lactate (>5 mmol/L), anion gap acidosis, increased lactate:pyruvate ratio, and metformin plasma levels generally >5 mcg/mL 1
• The FDA explicitly states that if metformin-associated lactic acidosis is suspected, immediate discontinuation is mandatory 1

Step 2: Identify and Treat the Underlying Cause

• Recognition and correction of the underlying process is the major step in treatment—lactic acidosis itself is almost always secondary to tissue hypoxia, sepsis, shock, or impaired lactate clearance 4, 5
• Address circulatory shock with volume resuscitation and vasopressors as needed 6
• Optimize oxygen delivery by treating respiratory failure, anemia, or cardiac dysfunction 5
• Treat sepsis aggressively with antibiotics and source control 2

Step 3: Consider Hemodialysis for Severe Cases

• Prompt hemodialysis is recommended for patients with a diagnosis or strong suspicion of metformin-associated lactic acidosis 1
• Metformin is dialyzable with clearance up to 170 mL/min under good hemodynamic conditions, and hemodialysis has often resulted in reversal of symptoms and recovery 1
• Hemodialysis corrects the acidosis and removes accumulated metformin simultaneously 1
• Continuous renal replacement therapy (CRRT) is NOT effective for severe lactic acidosis—lactate clearance via CRRT (even at high volumes of 7 L/h) is only ~79 mL/min, which is insufficient compared to rates of lactate overproduction in septic shock 7

Step 4: Supportive Measures and Monitoring

• General supportive measures should be instituted promptly in a hospital setting 1
• Sodium bicarbonate has limited utility—while it has been the traditional mainstay, aggressive use can lead to serious complications including increased lactate production, hypernatremia, and hypervolemia 4, 5
• Bicarbonate increases lactate production and provides little survival benefit 5
• Peritoneal dialysis with bicarbonate-based dialysate may deliver physiologic buffer without causing hypernatremia or hypervolemia, though evidence is limited 4

Step 5: Avoid Ineffective Therapies

• Dichloroacetate does NOT improve survival—despite stimulating pyruvate dehydrogenase and reducing lactate levels statistically, a large randomized controlled trial of 252 patients showed no improvement in hemodynamics or survival (only 12% dichloroacetate vs 17% placebo survived to discharge) 8
• Methylene blue showed little clinical efficacy despite initial theoretical promise 4

---

When to Restart Metformin After Resolution

• Confirm hemodynamic stability without vasopressor support before considering metformin restart 3
• Ensure renal function is stable with at least two consistent eGFR measurements showing ≥30 mL/min/1.73 m² 3, 9
• Reassess eGFR 48 hours after any contrast procedures or acute illness before restarting 1

---

Prevention: Risk Factors for Metformin-Associated Lactic Acidosis

Absolute Contraindications (eGFR <30 mL/min/1.73 m²)

• Discontinue metformin immediately if eGFR falls below 30 mL/min/1.73 m² 1, 2, 9
• Do not initiate metformin in patients with eGFR 30-44 mL/min/1.73 m² 1

High-Risk Clinical Scenarios Requiring Metformin Discontinuation

• Acute conditions with tissue hypoxia: sepsis, shock, severe hypoxia, acute heart failure 2, 3
• Impaired metformin clearance: acute kidney injury, significant renal impairment 2, 3
• Impaired lactate clearance: liver failure, alcoholism 2, 1
• Perioperative period: withhold metformin when patients have restricted food and fluid intake during surgery or procedures 1
• Iodinated contrast procedures: stop metformin in patients with eGFR 30-60 mL/min/1.73 m², history of liver disease, alcoholism, heart failure, or intra-arterial contrast administration 1, 2

Special Populations

• In hospitalized COVID-19 patients with type 2 diabetes, metformin use was associated with increased lactic acidosis incidence (adjusted HR 4.46,95% CI 1.11-18.0), particularly with higher doses, worse kidney function, and greater disease severity 2
• Measure lactate concentrations in fragile patients and withdraw metformin if elevated 2

---

Prognosis and Clinical Pearls

• Mortality in severe lactic acidosis is very high—only 12-17% of patients with severe lactic acidosis (lactate >11 mmol/L, pH ~7.24) survived to hospital discharge in clinical trials 8
• The case fatality rate underscores the importance of prevention through appropriate patient selection and monitoring 8, 6
• A case report documented successful recovery from MALA with metformin level of 42 mcg/mL (therapeutic: 1-2 mcg/mL) after multiple dialysis treatments, demonstrating the critical role of renal replacement therapy 6